$1.96
+0 (+0%)
At Close: Jun 03, 2026
SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.
06:05pm, Thursday, 23'rd Sep 2021
New York, New York--(Newsfile Corp. - September 23, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Cassava Sciences, In
Why Shares of Cassava Sciences Rose 15% Today
05:15pm, Thursday, 23'rd Sep 2021
Additional data is promising. But will investors trust it?
San Francisco, California--(Newsfile Corp. - September 23, 2021) - Hagens Berman urges Cassava Sciences, Inc. (NASDAQ: SAVA) investors with significant losses to submit your losses now.Class Period:
New York, New York--(Newsfile Corp. - September 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA)
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class a
Cassava (SAVA) Posts Top-Line Data from AD Study on Simufilam
12:14pm, Thursday, 23'rd Sep 2021
Cassava (SAVA) reports top-line data from an interim analysis of the on-going study evaluating simufilam in patients with mild-to-moderate Alzheimer's disease.
New York, New York--(Newsfile Corp. - September 23, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
MRM Stock: The Hair Salon Deal That has Holistic Healthcare Play Medirom All Lathered Up Today
10:16am, Thursday, 23'rd Sep 2021
Medirom Healthcare Technologies (MRM) stock is rocketing higher on Thursday following news of a major deal for the company. The post MRM Stock: The Hair Salon Deal That has Holistic Healthcare Play Me
Radnor, Pennsylvania--(Newsfile Corp. - September 22, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Cassava Sciences, Inc. (NASDAQ: SAVA) ("Cassava") investors that a securiti
SAVA: Berman Tabacco Alerts Investors with Losses Over $200,000 in Cassava Sciences, Inc. of Approaching Lead Plaintiff Deadline
04:15pm, Wednesday, 22'nd Sep 2021
Boston, Massachusetts--(Newsfile Corp. - September 22, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc
Should you buy SAVA stock in Q4 2021 amid positive Simufilam trial data?
03:19pm, Wednesday, 22'nd Sep 2021
On Wednesday, Cassava Sciences Inc. (NASDAQ:SAVA) shares swang to a net intraday loss of about 3.52%, as of this writing, despite spiking more than 21% in the morning. The stock surged after the compa
SAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?
02:48pm, Wednesday, 22'nd Sep 2021
Today, Cassava Sciences initially soared on the announcement of some positive preliminary data, before SAVA stock began selling off. The post SAVA Stock: What Is Going on With Red-Hot Cassava Sciences
Cassava Sciences' Simufilam Data Shows Improved Cognition In Alzheimer's Disease
11:16am, Wednesday, 22'nd Sep 2021
Cassava Sciences Inc (NASDAQ: SAVA) has announced top-line data from a pre-planned interim analysis of an ongoing open-label study of simufilam in mild-to-moderate Alzheimer's disease. Related Cont
Cassava Sciences Announces Top-line Results of 12-month Interim Analysis from Open-label Study Evaluating Simufilam in Alzheimer's Disease
08:30am, Wednesday, 22'nd Sep 2021
AUSTIN, Texas, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) announced top-line clinical data today from a pre-planned interim analysis of an on-going open-label study with
New York, New York--(Newsfile Corp. - September 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securitie
Sign In
Buy SAVA